Study of atheromatous plaque using intravascular ultrasound

Hellenic Journal of Cardiology

Volumn 49, Issue 6, 2008, Pages 415-421

  Sanidas, Elias A ^a   Vavuranakis, Manolis ^a,c   Papaioannou, Theodoros G ^a   Carlier, Stéphane ^b   Syros, George ^b   Dangas, George ^b   Stefanadis, Christodoulos ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b NewYork Presbyterian Hospital   (United States)

^c HIPPOKRATION HOSPITAL   (Greece)

Author keywords

Atherosclerosis; Imaging; Neovascularisation; Vasa vasorum; Vulnerable plaque

Indexed keywords

AMLODIPINE; ANTILIPEMIC AGENT; ATORVASTATIN; ENALAPRIL; PLACEBO; PRAVASTATIN;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; ANGIOCARDIOGRAPHY; ARTERY DIAMETER; ATHEROSCLEROTIC PLAQUE; BLOOD VESSEL DIAMETER; CLINICAL TRIAL; CORONARY ARTERY ATHEROSCLEROSIS; DISEASE SEVERITY; HUMAN; INTRAVASCULAR ULTRASOUND; REVIEW;

ATHEROSCLEROSIS; CORONARY ANGIOGRAPHY; HUMANS; MICROBUBBLES; NEOVASCULARIZATION, PATHOLOGIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 57149108524     PISSN: 10117970     EISSN: 10117970     Source Type: Journal    
DOI: None     Document Type: Review

References (49)

1. Murray CJ, Lopez AD. Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet. 1997; 349: 1436-1442.
2. Ringqvist I, Fisher LD, Mock M, et al. Prognostic value of angiographic indices of coronary artery disease from the Coronary Artery Surgery Study (CASS). J Clin Invest. 1983; 71: 1854-1866.
3. Ambrose JA, Tannenbaum MA, Alexopoulos D, et al. Angiographic progression of coronary artery disease and the development of myocardial infarction. J Am Coll Cardiol. 1988; 12: 56-62.
4. Schroeder AP, Falk E. Vulnerable and dangerous coronary plaques. Atherosclerosis. 1995; 118 (Suppl.): S141-149.
5. Schwartz SM, Virmani R, Rosenfeld ME. The good smooth muscle cells in atherosclerosis. Curr Atheroscler Rep. 2000; 2: 422-429.
6. Topol EJ, Nissen SE. Our preoccupation with coronary luminology. The dissociation between clinical and angiographic findings in ischemic heart disease. Circulation. 1995; 92: 2333-2342.
7. Ballantyne CM. Clinical trial endpoints: angiograms, events, and plaque instability. Am J Cardiol. 1998; 82: 5M-11M.
8. Niessen S. Application of intravascular ultrasound to characterize coronary artery disease and assess the progression or regression of atherosclerosis. Am J Cardiol. 2002; 89 (Suppl.): 24B-31B.
9. Sano K, Mintz GS, Carlier SG, et. al: Assessing intermediate left main coronary lesions using intravascular ultrasound. Am Heart J. 2007; 154: 983-988.
10. Lazaros G, Tsiamis E, Metallinos G, Stefanadis C. Ulcerated atheromatous plaque of the left main coronary artery in a patient with a recent extensive anterior myocardial infarction. Hellenic J Cardiol. 2007; 48: 108-109.
11. Nakamura S, Colombo A, Gaglione A, et al. Intracoronary ultrasound observations during stent implantation. Circulation. 1994; 89: 2026-2034.
12. Regar E, Klauss V, Werner F, et al. Quantitative changes in reference segments during IVUS-guided stent implantation: impact on the criteria for optimal stent expansion. Catheter Cardiovasc Interv. 1999; 47: 434-440.
13. Colombo A, Hall P, Nakamura S, et al. Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance. Circulation. 1995; 9: 1676-1688.
14. Guedes A, Keller PF, L'Allier PL, Lesperance J, Gregoire J, Tardif JC. Long-term safety of intravascular ultrasound in nontransplant, nonintervened, atherosclerotic coronary arteries. J Am Coll Cardiol. 2005; 45: 559-564.
15. Ramasubbu K, Schoenhagen P, Balghith MA, et al. Repeated intravascular ultrasound imaging in cardiac transplant recipients does not accelerate transplant coronary artery disease. J Am Coll Cardiol. 2003; 41: 1739-1743.
16. Falk E. Plaque rupture with severe pre-existing stenosis precipitating coronary thrombosis. Characteristics of coronary atherosclerotic plaques underlying fatal occlusive thrombi. Br Heart J. 1983; 50: 127-134.
17. Burke AP, Farb A, Malcom GT, Liang YH, Smialek J, Virmani R. Coronary risk factors and plaque morphology in men with coronary disease who died suddenly. N Engl J Med. 1997; 336: 1276-1282.
18. Toutouzas K, Stefanadis C. Advances in vulnerable plaque detection and treatment: how far have we gone? Hellenic J Cardiol. 2006; 47: 129-131.
19. Stefanadis C, Toutouzas K, Stefanadi E, Kolodgie F, Virmani R, Kipshidze N. First experimental application of bevacizumab-eluting PC coated stent for inhibition of vasa vasorum of atherosclerotic plaque: angiographic results in a rabbit atheromatic model. Hellenic J Cardiol. 2006; 47: 7-10.
20. Yamagishi M, Terashima M, Awano K, et al. Morphology of vulnerable coronary plaque: insights from follow-up of patients examined by intravascular ultrasound before an acute coronary syndrome. J Am Coll Cardiol. 2000; 35: 106-111.
21. Prati F, Arbustini E, Labellarte A, et al. Correlation between high frequency intravascular ultrasound and histomorphology in human coronary arteries. Heart. 2001; 85: 567-570.
22. Hiro T, Leung CY, De Guzman S, et al. Are soft echoes really soft? Intravascular ultrasound assessment of mechanical properties in human atherosclerotic tissue. Am Heart J. 1997; 133: 1-7.
23. Erbel R, Ge J, Gorge G, et al. Intravascular ultrasound classification of atherosclerotic lesions according to American Heart Association recommendation. Coron Artery Dis. 1999; 10: 489-499.
24. Nair A, Kuban BD, Tuzcu EM, Schoenhagen P, Nissen SE, Vince DG. Coronary plaque classification with intravascular ultrasound radiofrequency data analysis. Circulation. 2002; 106: 2200-2206.
25. Nair A, Kuban BD, Obuchowski N, Vince DG. Assessing spectral algorithms to predict atherosclerotic plaque composition with normalized and raw intravascular ultrasound data. Ultrasound Med Biol. 2001; 27: 1319-1331.
26. Nair A, Calvetti D, Vince DG. Regularized autoregressive analysis of intravascular ultrasound backscatter: improvement in spatial accuracy of tissue maps. IEEE Trans Ultrason Ferroelectr Freq Control. 2004; 51: 420-431.
27. Coleman DJ, Lizzi FL. Computerized ultrasonic tissue characterization of ocular tumors. Am J Ophthalmol. 1983; 96: 165-175.
28. Stahr PM, Hofflinghaus T, Voigtlander T, et al. Discrimination of early/intermediate and advanced/complicated coronary plaque types by radiofrequency intravascular ultrasound analysis. Am J Cardiol. 2002; 90: 19-23.
29. Kawasaki M, Sano K, Okubo M, et al. Volumetric quantitative analysis of tissue characteristics of coronary plaques after statin therapy using three-dimensional integrated backscatter intravascular ultrasound. J Am Coll Cardiol. 2005; 45: 1946-1953.
30. Leber AW, Becker A, Knez A, et al. Accuracy of 64-slice computed tomography to classify and quantify plaque volumes in the proximal coronary system: a comparative study using intravascular ultrasound. J Am Coll Cardiol. 2006; 47: 672-677.
31. Worthley SG, Helft G, Fuster V, et al. A novel nonobstructive intravascular MRI coil: in vivo imaging of experimental atherosclerosis. Arterioscler Thromb Vasc Biol. 2003; 23: 346-350.
32. Kawasaki M, Takatsu H, Noda T, et al. Noninvasive quantitative tissue characterization and two-dimensional color-coded map of human atherosclerotic lesions using ultrasound integrated backscatter: comparison between histology and integrated backscatter images. J Am Coll Cardiol. 2001; 38: 486-492.
33. Kawasaki M, Takatsu H, Noda T, et al. In vivo quantitative tissue characterization of human coronary arterial plaques by use of integrated backscatter intravascular ultrasound and comparison with angioscopic findings. Circulation. 2002; 105: 2487-2492.
34. Schaar JA, Regar E, Mastik F, et al. Incidence of high-strain patterns in human coronary arteries: assessment with three-dimensional intravascular palpography and correlation with clinical presentation. Circulation. 2004; 109: 2716-2719.
35. Schaar JA, de Korte CL, Mastik F, et al. Intravascular palpography for high-risk vulnerable plaque assessment. Herz. 2003; 28: 488-495.
36. Schaar JA, van der Steen AFW, Mastik F, Baldewsing RA, Serruys PW. Intravascular palpography for vulnerable plaque assessment. J Am Coll Cardiol. 2006; 47: 86-91.
37. Sangiorgi GM, Clementi F, Cola C, Biondi-Zoccai G. Plaque vulnerability and related coronary event prediction by intravascular ultrasound with virtual histology: "It's a long way to Tipperary"? Catheter Cardiovasc Interv. 2007; 70: 203-210.
38. Rodriguez-Granillo GA, Agostoni P, Garcia-Garcia HM, de Feyter P, Serruys PW. In-vivo, cardiac-cycle related intimal displacement of coronary plaques assessed by 3-D ECG-gated intravascular ultrasound: exploring its correlate with tissue deformability identified by palpography. Int J Cardiovasc Imaging. 2006; 22: 147-152.
39. Vavuranakis M, Papaioannou TG, Kakadiaris I, et al. Detection of perivascular blood flow in vivo by contrast-enhanced intracoronary ultrasonography and image analysis: an animal study. Clin Exp Pharmacol Physiol. 2007; 34: 1319-1323.
40. Vavuranakis M, Kakadiaris IA, O'Malley SM, et al. A new method for assessment of plaque vulnerability based on vasa vasorum imaging, by using contrast enhanced intravascular ultrasound and differential image analysis. Int J Cardiol. 2008; 130: 23-29.
41. Ishikawa K, Tani S, Watanabe I, et al. Effect of pravastatin on coronary plaque volume. Am J Cardiol. 2003; 92: 975-977.
42. Jensen LO, Thayssen P, Pedersen KE, Stender S, Haghfelt T. Regression of coronary atherosclerosis by simvastatin: a serial intravascular ultrasound study. Circulation. 2004; 110: 265-270.
43. Von Birgelen C, Hartmann M, Mintz GS, Baumgart D, Schmermund A, Erbel R. Relation between progression and regression of atherosclerotic left main coronary artery disease and serum cholesterol levels as assessed with serial long-term (> or =12 months) follow-up intravascular ultrasound. Circulation. 2003; 108: 2757-2762.
44. Von Birgelen C, Hartmann M, Mintz GS, et al. Relationship between cardiovascular risk as predicted by established risk scores versus plaque progression as measured by serial intravascular ultrasound in left main coronary arteries. Circulation. 2004; 110: 1579-1585.
45. Dangas G, Mintz GS, Mehran R, et al. Preintervention arterial remodeling as an independent predictor of target-lesion revascularization after nonstent coronary intervention: an analysis of 777 lesions with intravascular ultrasound imaging. Circulation. 1999; 99: 3149-3154.
46. Schartl M, Bocksch W, Koschyk DH, et al. Use of intravascular ultrasound to compare effects of different strategies of lipid-lowering therapy on plaque volume and composition in patients with coronary artery disease. Circulation. 2001; 104: 387-392.
47. Okazaki S, Yokoyama T, Miyauchi K, et al. Early statin treatment in patients with acute coronary syndrome: demonstration of the beneficial effect on atherosclerotic lesions by serial volumetric intravascular ultrasound analysis during half a year after coronary event: the ESTABLISH Study. Circulation. 2004; 110: 1061-1068.
48. Nissen SE, Tuzcu EM, Schoenhagen P, et al. Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial. JAMA. 2004; 291: 1071-1080.
49. Nissen SE, Tuzcu EM, Libby P, et al. Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trial. JAMA. 2004; 292: 2217-2225.